Congress temporarily suspends tariffs on imported formula to reduce cost
The Senate today passed and sent to the president for his signature the Formula Act (H.R. 8351), bipartisan legislation that would suspend tariffs on imported infant formula through 2022. The Food and Drug Administration has allowed formula imports to help address a U.S. formula shortage, but tariffs have increased the retail cost of these products. The Department of Health and Human Services offers a webpage to help health care providers and families locate formula.
Related News Articles
Headline
The award-winning Beyond Birth podcast series helps bring hospital programs to life by telling personal stories of how they positively impact mothers and their…
Blog
Our health may be the most personal and important thing we have. It determines how we feel when we wake up in the morning, how we relate to our families and…
Headline
Health care organizations can create more inclusive, responsive and effective maternal health initiatives that address the unique challenges Black women…
Blog
Black women in the U.S. experience maternal mortality rates at nearly three times that of white women, regardless of income or education level. This…
Headline
Given the pressures of parenting, learn how health care organizations are supporting new moms to enable them to thrive at work, and most importantly, at home,…
Headline
Mounting pressures on the health care workforce have created a crisis with short-term staffing shortages and a long-range picture of an unfulfilled talent…